文献速递胃肠外科围术期管理与 ERAS

术前抑郁状态与代谢减重手术5年结局:PCORnet队列研究

Preoperative Depression Status and 5 Year Metabolic and Bariatric Surgery Outcomes in the PCORnet Bariatric Study Cohort.
PubMed 文献 · Ann Surg · 2022-01-19

该研究基于PCORnet减重研究队列,纳入23个卫生系统2005-2015年接受袖状胃切除(SG;n=16,158)或胃旁路术(RYGB;n=20,713)的36,871例患者,评估术前一年抑郁诊断对5年体重丢失、糖尿病及安全性/利用结局的影响。结果显示抑郁组与非抑郁组结局总体相似,抑郁的影响相较术式选择在临床上较小。

要点

  • SG患者术前抑郁占27.1%,RYGB患者占33.0%,抑郁组内外科及精神共病更多。
  • 5年随访时RYGB后抑郁组%TWL略低于非抑郁组(组间差=0.42%TWL,P=0.04),SG后无此差异。
  • 抑郁对糖尿病缓解/复发、再手术、修正手术或死亡率无调节作用,但调节内镜和重复住院风险(RYGB vs SG)。

核心结论

  • 接受RYGB和SG的抑郁患者体重丢失、糖尿病及安全性/利用结局与非抑郁患者相似。
  • 抑郁的影响相较术式选择在临床上较小。

研究设计与样本

  • PCORnet减重研究队列,提取23个卫生系统2005-2015年36,871例接受SG(n=16,158)或RYGB(n=20,713)患者数据。
  • 评估术前一年有或无抑郁诊断患者在术后1、3、5年的%TWL、糖尿病结局及术后安全性/利用结局。

主要发现

  • SG患者术前抑郁占27.1%,RYGB患者占33.0%,抑郁组内外科及精神共病更多。
  • 5年随访时RYGB后抑郁组较非抑郁组%TWL略低(组间差=0.42%TWL,P=0.04),SG后无差异。
  • RYGB后抑郁组较非抑郁组HbA1c改善略大(组间差=-0.19,P=0.04),SG后无差异。
  • 基线抑郁未调节糖尿病缓解或复发、再手术、修正手术或死亡率(跨术式)。
  • 基线抑郁调节RYGB vs SG的内镜和重复住院风险。

临床怎么用

  • 术前应评估抑郁状态,因其与更多共病相关,但抑郁不应作为排除RYGB或SG的依据。
  • 抑郁患者术后体重丢失和糖尿病结局与非抑郁患者相似,术式选择对结局影响更大。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine whether depression status before metabolic and bariatric surgery (MBS) influenced 5-year weight loss, diabetes, and safety/utilization outcomes in the PCORnet Bariatric Study. SUMMARY OF BACKGROUND DATA: Research on the impact of depression on MBS outcomes is inconsistent with few large, long-term studies. METHODS: Data were extracted from 23 health systems on 36,871 patients who underwent sleeve gastrectomy (SG; n=16,158) or gastric bypass (RYGB; n=20,713) from 2005-2015. Patients with and without a depression diagnosis in the year before MBS were evaluated for % total weight loss (%TWL), diabetes outcomes, and postsurgical safety/utilization (reoperations, revisions, endoscopy, hospitalizations, mortality) at 1, 3, and 5 years after MBS. RESULTS: 27.1% of SG and 33.0% of RYGB patients had preoperative depression, and they had more medical and psychiatric comorbidities than those without depression. At 5 years of follow-up, those with depression, versus those without depression, had slightly less %TWL after RYGB, but not after SG (between group difference = 0.42%TWL, P = 0.04). However, patients with depression had slightly larger HbA1c improvements after RYGB but not after SG (between group difference = - 0.19, P = 0.04). Baseline depression did not moderate diabetes remission or relapse, reoperations, revision, or mortality across operations; however, baseline depression did moderate the risk of endoscopy and repeat hospitalization across RYGB versus SG. CONCLUSIONS: Patients with depression undergoing RYGB and SG had similar weight loss, diabetes, and safety/utilization outcomes to those without depression. The effects of depression were clinically small compared to the choice of operation.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Coughlin JW, Nauman E, Wellman R, et al. Preoperative Depression Status and 5 Year Metabolic and Bariatric Surgery Outcomes in the PCORnet Bariatric Study Cohort. Ann Surg. 2022. PMID: 35058404. doi:10.1097/SLA.0000000000005364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。